Letermovir and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported as a side effect among people who take Letermovir (letermovir), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Cyclosporine, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Acute kidney failure when taking Letermovir. It is created by eHealthMe based on reports of 949 people who have side effects when taking Letermovir from the FDA, and is updated regularly.

What is Letermovir?

Letermovir has active ingredients of letermovir. eHealthMe is studying from 949 Letermovir users. Check the latest studies of Letermovir.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,836 drugs and 4,497 conditions by eHealthMe. Check the latest studies of Acute kidney failure.

On Aug, 06, 2026

949 people reported to have side effects when taking Letermovir.
Among them, 16 people (1.69%) have Acute kidney failure.

Could Letermovir cause Acute kidney failure?

Among these 16 people:

How long have people been on Letermovir when they have Acute kidney failure? *

What is the gender of people who have Acute kidney failure when taking Letermovir? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Acute kidney failure when taking Letermovir? *

What are other drugs people take besides Letermovir? *

Tacrolimus: 8 people, 50.00%
Cyclosporine: 8 people, 50.00%
Mycophenolate Mofetil: 7 people, 43.75%
Everolimus: 7 people, 43.75%
Ganciclovir: 6 people, 37.50%
Valganciclovir Hydrochloride: 4 people, 25.00%
Posaconazole: 4 people, 25.00%
Foscavir: 3 people, 18.75%
Lovenox: 3 people, 18.75%
Prednisone: 2 people, 12.50%

What are other side effects people have besides Acute kidney failure? *

Drug Resistance (reduction in effectiveness of a drug): 6 people, 37.50%
Dehydration (dryness resulting from the removal of water): 6 people, 37.50%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 37.50%
Diarrhea: 6 people, 37.50%
Pathogen Resistance: 4 people, 25.00%
Cytomegalovirus Colitis (an inflammation of the colon from virus): 4 people, 25.00%
Haemoperitoneum (presence of blood in the peritoneal cavity): 3 people, 18.75%
Hepatic Failure (liver failure): 3 people, 18.75%
Blood Stem Cell Transplant Failure: 3 people, 18.75%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 1 person, 6.25%

What are the existing conditions these people have? *

Immunodeficiency Disorders: 7 people, 43.75%
Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 6 people, 37.50%
Cytomegalovirus Colitis (an inflammation of the colon from virus): 6 people, 37.50%
Cytomegalovirus Infection: 5 people, 31.25%
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Letermovir and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Letermovir:

Letermovir (949 reports)

Browse all side effects of Letermovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute kidney failure:

Acute kidney failure (2,836 drugs)

Browse all the conditions that are associated with Acute kidney failure:

Acute kidney failure (4,497 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on letermovir (the active ingredients of Letermovir) and Letermovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.